oleandomycin

oleandomycin is a lipid of Polyketides (PK) class. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Methylation, enzyme activity, Anabolism and Biosynthetic Pathways. Oleandomycin often locates in Chromosomes and Protoplasm. The associated genes with oleandomycin are resistance genes, Open Reading Frames, CTTNBP2 gene, Gene Feature and Gene Clusters.

Cross Reference

Introduction

To understand associated biological information of oleandomycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oleandomycin?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oleandomycin

MeSH term MeSH ID Detail
Bacterial Infections D001424 21 associated lipids
Body Weight D001835 333 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with oleandomycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oleandomycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oleandomycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oleandomycin?

There are no associated biomedical information in the current reference collection.

What genes are associated with oleandomycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oleandomycin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with oleandomycin

Download all related citations
Per page 10 20 50 100 | Total 663
Authors Title Published Journal PubMed Link
pmid:
CUPPLES JF and PERRY AW Acute staphylococcal endocarditis treated successfully with tetracycline-oleandomycin. 1957 Can Med Assoc J pmid:13472537
JONES WF and FINLAND M Antibiotic combinations; tetracycline, erythromycin, oleandomycin and spiramycin and combinations of tetracycline with each of the other three agents; comparisons of activity in vitro and antibacterial action of blood after oral administration. 1957 N. Engl. J. Med. pmid:13464978
ERYTHROMYCIN, oleandomycin and spiramycin- and their combinations with tetracycline. 1957 N. Engl. J. Med. pmid:13464974
JONES WF and FINLAND M Antibiotic combinations; tetracycline, erythromycin, oleandomycin and spiramycin, and combinations of tetracycline with each of the other three agents; comparisons of activity in vitro and antibacterial action of blood after oral administration. 1957 N. Engl. J. Med. pmid:13464964
FAIRBROTHER RW and SOUTHALL JE In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin. 1957 Lancet pmid:13482262
LEVITT RO and HUBBLE RH In vitro effect of a tetracycline-oleandomycin mixture (PA 775) on staphylococci. 1957 N. Engl. J. Med. pmid:13452068
FINLAND M and JONES WF Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasma of normal subjects after oral doses of penicillin, oleandomycin and combinations of these antibiotics. 1957 N. Engl. J. Med. pmid:13388042
KANEE B and COCKCROFT WH Clinical and bacteriological studies on signemycin (oleandomycin-tetracycline) ointment. 1958 Can Med Assoc J pmid:13536931
OATES JK Trial of sigmamycin in nonspecific urethritis. 1958 Br J Vener Dis pmid:13523198
KOCH R and ASAY LD Oleandomycin, a laboratory and clinical evaluation. 1958 J. Pediatr. pmid:13599086
LEACH W Treatment of non-gonococcal urethritis with sigmamycin. A controlled method of investigation. 1959 Br J Vener Dis pmid:14414930
LOWBURY EJ and HURST L The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. 1959 J. Clin. Pathol. pmid:13641436
WEITHOFER W [Sigmamycin in pediatrics]. 1959 Medizinische pmid:13843801
BELONSCHKIN B and LINDGREN M [Experiences with sigmamycin in gynecology and obstetrics]. 1959 Sven Lakartidn pmid:13798643
BOLOGNESI C and MANARA E [Results of the use, in pyogenic diseases of the ear, nose and throat, of a new antibiotic combination with synergistic action]. 1959 Otorinolaringol Ital pmid:13802351
CITTERIO C and CORIANDOLI EM [Rectal absorption of oleandomycin]. 1959 Boll. Soc. Ital. Biol. Sper. pmid:13810380
CSONKA GW Treatment of non-specific urethritis with tri-acetyl-oleandomycin. 1959 Br J Vener Dis pmid:13813183
DRYJSKI J [Preliminary observations on the application of sigmamycin in surgery]. 1959 Pol Tyg Lek pmid:13818251
WILLCOX RR Treatment of non-gonococcal urethritis with tri-acetyl-oleandomycin. 1959 Br J Vener Dis pmid:13844788
LOVEMAN AB and HAMMOND K Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J. 1959 J Ky Med Assoc pmid:13853712
GERNER G [Experimental and clinical experiences with the combination of tetracycline and oleandomycin]. 1959 Arzneimittelforschung pmid:13827557
GRAZIA G [The oleandomycin-tetracycline combination in therapy of diphtheritis]. 1959 Clin Pediatr (Bologna) pmid:13829153
TERRAGNA A and SCARABICCHI S [Oleandomycin therapy of carriers of diphtheria bacilli]. 1959 Minerva Med. pmid:13837499
TERRIER G [On the use in otorhinolaryngology of an antibiotic compound (sigmamycin)]. 1959 Praxis pmid:13837514
TYC M et al. [Essay with the production of oleandomycin]. 1959 Med Dosw Mikrobiol pmid:13840079
FRAGA S [A new antibiotic entity in dermatology]. 1959 Rev Bras Med pmid:13824300
FRANK L and STRITZLER C Long-term therapy of acne with antibiotics. 1959 N Y State J Med pmid:13824512
MURDOCH JM et al. An evaluation of continuous antibiotic therapy in chronic bronchitis. 1959 Br Med J pmid:14425339
PFANNMUELLER W [Clinical experiences with combined antibiotic therapy with a tetracycline-oleandomycin combination]. 1959 Arztl Wochensch pmid:14432512
PORRAZZO F [On the medical treatment of pulmonary abscess]. 1959 Gazz Med Ital pmid:14434237
PRZYBYLKIEWICZ Z and ZGORNIAK-NOWOSIELSKA I [Studies on the in vitro sensitivity of strains of Micrococcus pyogenes var. aureus to tetracycline, oleandomycin and mixtures of tetracycline and oleandomycin]. 1959 Pol Tyg Lek pmid:14435191
RIOS MOZO M and LOPEZ ROMASANTA E [Clinical use of the tetracycline-oleandomycin association]. 1959 Hisp Med pmid:14437530
RIPBERGER FM et al. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin. 1959 Antibiotic Med Clin Ther (New York) pmid:14437535
SCHAUMKELL KW [Report on the clinical use of oleandomycin and of an oleandomycin-tetracycline combination in gynecology (with special reference to intravenous application)]. 1959 Medizinische pmid:14442496
HINTON NA and WILSON DL A comparison of three forms of oleandomycin. 1959 Antibiot Chemother (Northfield) pmid:14401914
NUMEROFF M et al. Falsely elevated values for urinary 17-ketosteroids and 17-hydroxycorticoids associated with ingestion of triacetyloleandomycin. 1959 J. Clin. Endocrinol. Metab. pmid:14427898
JOHNE HO [Clinical experiences with a new oleandomycinester (oleandocyn)]. 1959 Medizinische pmid:14407401
PAYET M and SANKALE M [First trials of sigmamycin in Africans]. 1959 Mar-Apr Bull Soc Pathol Exot Filiales pmid:14431135
DE MORAES F and PATTO O [Oleandomycin and bone infections]. 1959 Sep-Oct Acta Orthop Belg pmid:13814938
BURDACH R et al. The use of tetracycline-oleandomycin combination in the acute pneumonopathies of infancy, with particular considerations of staphylococcic empyema. 1959-1960 Antibiot Annu pmid:13806013
YAZIGI R et al. In vitro study of the action of a tetracycline-oleandomycin preparation. Tetracycline, oleandomycin, and chloramphenicol on Staphylococcus, Escherichia coli, and Klebsiella. 1959-1960 Antibiot Annu pmid:13846497
GREIF MS The use of a tetracycline-oleandomycin preparation in the treatment of cholecystitis and cholangitis. 1959-1960 Antibiot Annu pmid:13851718
TORRA AM and SALDANA TATE L Studies on the emergence of oleandomycin-tetracycline combination resistant strains of staphylococci. 1959-1960 Antibiot Annu pmid:13838929
FRAGA S and dos SANTOS E One hundred eight cases of pyogenic dermatitis treated with a combination of oxytetracycline and oleandomycin. 1959-1960 Antibiot Annu pmid:13824299
LEFEBVRE M et al. Triacetyloleandomycin: a report on its use in a general hospital. 1959-1960 Antibiot Annu pmid:14415263
MORADOR JL et al. Three years of clinical experience with oleandomycin-tetracycline combination in the treatment of staphylococal infections. I. Clinical and experimental comparative studies. 1959-1960 Antibiot Annu pmid:14423932
MORGINSON WJ and ESKELSON YD The role of triacetyloleandomycin in the treatment of pustular and cystic acne: a double blind study. 1959-1960 Antibiot Annu pmid:14424141
MOU TW Experiences with triacetyloleandomycin in a rheumatic fever prophylaxis clinic. 1959-1960 Antibiot Annu pmid:14424692
OLANSKY S and MCCORMICK GE Triacetyloleandomycin: further observations on the treatment of acne and pyodermas. 1959-1960 Antibiot Annu pmid:14428587